Clinical prognostic factors for disabling Crohn's disease: A systematic review and meta-analysis

World Journal of Gastroenterology

Volumn 19, Issue 24, 2013, Pages 3866-3871

  Dias, Cláudia Camila ^a   Rodrigues, Pedro Pereira ^a   da Costa Pereira, Altamiro ^a   Magro, Fernando ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Crohn's disease; Disabling disease; Meta analysis; Outcome; Prognostic factors; Systematic review

Indexed keywords

CORTICOSTEROID;

AGE; ARTICLE; CROHN DISEASE; DISEASE EXACERBATION; HUMAN; META ANALYSIS; OBSERVATIONAL STUDY; PROGNOSIS; QUALITY CONTROL; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 84879583870     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i24.3866     Document Type: Article

References (11)

1. Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010; 105: 289-297 [PMID: 19861953 DOI: 10.1038/ajg.2009.579]
2. Casellas F, López-Vivancos J, Vergara M, Malagelada J. Impact of inflammatory bowel disease on health-related quality of life. Dig Dis 1999; 17: 208-218 [PMID: 10754360 DOI: 10.1159/000016938]
3. Devlin SM, Panaccione R. Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up. Med Clin North Am 2010; 94: 1-18 [PMID: 19944795 DOI: 10.1016/ j.mcna.2009.08.017]
4. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560 [PMID: 12958120]
5. Sirriyeh R, Lawton R, Gardner P, Armitage G. Reviewing studies with diverse designs: the development and evaluation of a new tool. J Eval Clin Pract 2012; 18: 746-752 [PMID: 21410846]
6. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006; 130: 650-656 [PMID: 16530505 DOI: 10.1053/j.gastro.2005.12.019]
7. Loly C, Belaiche J, Louis E. Predictors of severe Crohn's disease. Scand J Gastroenterol 2008; 43: 948-954 [PMID: 19086165 DOI: 10.1080/00365520801957149]
8. Yang CH, Ding J, Gao Y, Chen X, Yang ZB, Xiao SD. Risk factors that predict the requirement of aggressive therapy among Chinese patients with Crohn's disease. J Dig Dis 2011; 12: 99-104 [PMID: 21401894 DOI: 10.1111/j.1751-2980. 2011.00484.x]
9. Munkholm P, Langholz E, Davidsen M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994; 35: 360-362 [PMID: 8150347 DOI: 10.1136/ gut.35.3.360]
10. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroen-terology 2000; 119: 895-902 [PMID: 11040176 DOI: 10.1053/gast.2000.18144]
11. Feagan BG, Panaccione R, Sandborn WJ, D'Haens GR, Schreiber S, Rutgeerts PJ, Loftus EV, Lomax KG, Yu AP, Wu EQ, Chao J, Mulani P. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology 2008; 135: 1493-1499 [PMID: 18848553 DOI: 10.1053/j.gastro.2008. 07.069]